A Drug Drug Interaction (DDI) Study of Pirtobrutinib (LY3527727) and Rosuvastatin in Healthy Participants
Clinical trial NCT05176314 · COMPLETED
Trial details
- NCT number
- NCT05176314
- Sponsor
- Loxo Oncology, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-11
- Primary completion
- 2022-04-20
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.